Mucosal Healing in Celiac Disease: Villous Architecture and Immunohistochemical Features in Children on a Long-Term Gluten Free Diet.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 Sep 2022
Historique:
received: 21 07 2022
revised: 24 08 2022
accepted: 31 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Considerable heterogeneity exists across studies assessing intestinal mucosal recovery in celiac (CD) patients on a gluten-free diet (GFD). We aimed at investigating histological and immunohistochemical features in CD patients on a long-term GFD and to correlate them to the GFD duration. Morphometrical and immunohistochemical analysis were retrospectively performed on duodenal biopsies in three groups of children: 33 on a long-term (>2 years) GFD (GFD-group), four of which remained seropositive despite dietary adherence, 31 with villous atrophy (ACD-group) and 76 heathy, non-celiac (CTR-group). Moreover, in the GFD-group, we correlated immunohistochemical alterations to the GFD duration. The villous to crypt (V/C) ratio significantly improved after the GFD and completely normalized in all patients, becoming even higher than in the CTR-group (median value 3.2 vs. 3, p = 0.007). In parallel, the number of CD3+ and TCRγδ+ cells in the epithelium were significantly reduced in the GFD compared to ACD patients, even if they remained higher than in the CTR-group (p < 0.05). In contrast, CD25+ cells in the lamina propria significantly decreased after the GFD (p < 0.05) and become comparable to the CTR-group (p = 0.9). In the GFD-group there was no difference in the immunohistochemical parameters between seropositive and seronegative patients and alterations did not correlate to GFD length. In conclusion, a GFD is able to both restore a normal V/C ratio and reduce inflammation, but the epithelium maintains some stigmata of the disorder, such as an increased number of CD3+ and TCRγδ+ cells. These alterations persist regardless of the duration of the GFD.

Identifiants

pubmed: 36145072
pii: nu14183696
doi: 10.3390/nu14183696
pmc: PMC9504881
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Gastrointest Endosc. 2003 Feb;57(2):187-91
pubmed: 12556782
Rev Esp Enferm Dig. 2020 Feb;112(2):101-108
pubmed: 31880159
Annu Rev Immunol. 2011;29:493-525
pubmed: 21219178
Gastroenterology. 2015 Sep;149(3):681-91.e10
pubmed: 26001928
Am J Gastroenterol. 2003 Jun;98(6):1332-7
pubmed: 12818278
Clin Exp Immunol. 2014 Sep;177(3):611-7
pubmed: 24773630
Nutrients. 2018 Nov 18;10(11):
pubmed: 30453686
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):286-291
pubmed: 28112686
Semin Immunopathol. 2012 Jul;34(4):551-66
pubmed: 22660791
Nat Med. 2012 Feb 26;18(3):441-5
pubmed: 22366952
Cell. 2019 Feb 21;176(5):967-981.e19
pubmed: 30739797
J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):267-269
pubmed: 28489675
J Clin Gastroenterol. 2019 Aug;53(7):507-513
pubmed: 29505551
Gastrointest Endosc. 2004 Jan;59(1):158-9; author reply 159-60
pubmed: 14740630
J Immunol. 2018 Jul 15;201(2):747-756
pubmed: 29884699
Adv Sci (Weinh). 2021 Jan 04;8(4):2003526
pubmed: 33643806
J Pediatr Gastroenterol Nutr. 2020 Jan;70(1):141-156
pubmed: 31568151
Am J Gastroenterol. 2012 Oct;107(10):1563-9
pubmed: 22825364
PLoS One. 2013 Oct 18;8(10):e76006
pubmed: 24204586
Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2
pubmed: 29551598
J Pediatr Gastroenterol Nutr. 2015 May;60(5):621-5
pubmed: 25514620
Nutrients. 2016 Aug 26;8(9):
pubmed: 27571100
Am J Gastroenterol. 2005 Oct;100(10):2294-8
pubmed: 16181383
Dig Dis Sci. 2011 Jul;56(7):2042-9
pubmed: 21221796
PLoS One. 2017 Nov 2;12(11):e0187526
pubmed: 29095937
Am J Gastroenterol. 2010 Jun;105(6):1412-20
pubmed: 20145607
Scand J Gastroenterol. 2011 Oct;46(10):1194-205
pubmed: 21843037
Scand J Gastroenterol. 2016 Dec;51(12):1439-1446
pubmed: 27534885
J Physiol Biochem. 2018 Feb;74(1):153-158
pubmed: 28815514
Cell Mol Gastroenterol Hepatol. 2021;11(1):13-32
pubmed: 32745639

Auteurs

Roberta Mandile (R)

Department of Translational Medical Science, Pediatrics Section University Federico II, via Pansini 5, 80131 Naples, Italy.

Mariantonia Maglio (M)

European Laboratory for the Investigation of Food Induced Disease (ELFID), University Federico II, via Pansini 5, 80131 Naples, Italy.

Caterina Mosca (C)

Department of Translational Medical Science, Pediatrics Section University Federico II, via Pansini 5, 80131 Naples, Italy.

Antonella Marano (A)

European Laboratory for the Investigation of Food Induced Disease (ELFID), University Federico II, via Pansini 5, 80131 Naples, Italy.

Valentina Discepolo (V)

Department of Translational Medical Science, Pediatrics Section University Federico II, via Pansini 5, 80131 Naples, Italy.
European Laboratory for the Investigation of Food Induced Disease (ELFID), University Federico II, via Pansini 5, 80131 Naples, Italy.

Riccardo Troncone (R)

Department of Translational Medical Science, Pediatrics Section University Federico II, via Pansini 5, 80131 Naples, Italy.
European Laboratory for the Investigation of Food Induced Disease (ELFID), University Federico II, via Pansini 5, 80131 Naples, Italy.

Renata Auricchio (R)

Department of Translational Medical Science, Pediatrics Section University Federico II, via Pansini 5, 80131 Naples, Italy.
European Laboratory for the Investigation of Food Induced Disease (ELFID), University Federico II, via Pansini 5, 80131 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH